삼성서울병원

Ko En
의료진 검색
찾으실 의료진명을 입력하여 검색해주세요.

신경외과 설호준 교수

진료분야
두개저종양, 뇌신경종양, 악성뇌종양, 뇌하수체종양, 뇌외상, 감마나이프
진료일정 04 月
날짜
수
01
목
02
금
03
토
04
일
05
월
06
화
07
수
08
목
09
금
10
토
11
일
12
월
13
화
14
수
15
목
16
금
17
토
18
일
19
월
20
화
21
수
22
목
23
금
24
토
25
일
26
월
27
화
28
수
29
목
30
오전
오후
진료일정 05 月
날짜
금
01
토
02
일
03
월
04
화
05
수
06
목
07
금
08
토
09
일
10
월
11
화
12
수
13
목
14
금
15
토
16
일
17
월
18
화
19
수
20
목
21
금
22
토
23
일
24
월
25
화
26
수
27
목
28
금
29
토
30
일
31
오전
오후
본원외래 본원클리닉 본원육아상담 암병원외래 암병원클리닉 암병원육아상담

학력

학력
2007.02 서울대학교 대학원 의학과 (박사)
2004.02 서울대학교 대학원 의학과 (석사)
1994.02 서울대학교 의과대학 졸업 (의학사)

경력

경력
2019.03 ~현재 성균관대학교 의과대학 신경외과학교실 교수
2010.03 ~현재 삼성서울병원 신경외과 전문의
2013.03 ~ 2019.02 성균관대학교 의과대학 신경외과학교실 부교수
2010.03 ~ 2013.02 삼성서울병원 신경외과 임상부교수
2006.04 ~ 2010.02 강원대학교 의학전문대학원 의학과 조교수
2007.08 ~ 2009.06 Toronto univ. Hospital for Sick Children, Labatt Brain Tumor Research Center, . Research fellow
2004.03 ~ 2006.03 강원대학교 의과대학 의학과 전임강사
2003.03 ~ 2004.02 서울대학교병원 신경외과 뇌종양 및 뇌정위 분야 전임의
1999.03 ~ 2003.02 서울대학교병원 신경외과 레지던트 과정 수료
1994.03 ~ 1995.02 서울대학교병원 인턴 과정 수료

연구분야

연구분야
두개저 종양, 뇌종양, 뇌하수체 종양
수술적 치료가 매우 중요한 두개저 종양 및 뇌종양 환자의 최첨단 수술 기법에 대한 임상적 치료 및 연구에 매진하고 있으며, 향후 난치성 악성 뇌종양에 대한 신치료 기법 및 환자 맞춤형 치료를 위한 기초 및 중개연구를 담당함.

학회활동

학회활동
대한소아뇌종양학회 종신회원
2011.03 ~ 현재 대한신경종양학회 정회원
2005.03 ~ 현재 대한두개저외과학회 정회원
2005.03 ~ 현재 대한뇌종양학회 정회원
  • " alt="" />
  • " alt="" />

환자와 함께 뇌종양이라는 암벽을 등반해나가는 뇌종양 전문의 신경외과 설호준 교수

Oh Happy SMC 블로그
논문
  • EXP MOL MED 2019 10.1038/s12276-019-0351-y Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target Han1, S; Shin, H; Lee, JK; Liu, ZQ; Rabadan, R; Lee, J; Shin, J; Lee, C; Yang, H; Kim, D; Kim, SH; Kim, J; Oh, JW; Kong, DS; Lee, JI; Seol, HJ; Choi, JW; Kang, HJ; Nam, DH
    View PubMed
  • J NEURO-ONCOL 2019 10.1007/s11060-019-03328-3 Fractionated stereotactic radiosurgery for malignant gliomas: comparison with single session stereotactic radiosurgery Choi1, SW; Cho, KR; Choi, JW; Kong, DS; Seol, HJ; Nam, DH; Lee, JI
    View PubMed
  • WORLD NEUROSURG 2019 10.1016/j.wneu.2019.07.218 Clinical Significance of Tumor-Related Edema of Optic Tract Affecting Visual Function in Patients with Sellar and Suprasellar Tumors Ju1, DG; Jeon, C; Kim, KH; Park, KA; Hong, SD; Seoul, HJ; Shin, HJ; Nam, DH; Lee, JI; Kong, DS
    View PubMed
  • WORLD NEUROSURG 2019 10.1016/j.wneu.2019.08.031 Clinical Efficacy of Optical Coherence Tomography to Predict the Visual Outcome After Endoscopic Endonasal Surgery for Suprasellar Tumors Jeon1, C; Park, KA; Hong, SD; Choi, JW; Seol, HJ; Nam, DH; Lee, JI; Shin, HJ; Kong, DS
    View PubMed
  • NEUROSURG REV 2019 10.1007/s10143-019-01213-1 Comparison between retrosigmoid and translabyrinthine approaches for large vestibular schwannoma: focus on cerebellar injury and morbidities Kim1, KH; Cho, YS; Seol, HJ; Cho, KR; Choi, JW; Kong, DS; Shin, HJ; Nam, DH; Lee, JI
    View PubMed
  • J NEUROSURG 2019 10.3171/2018.6.JNS181099 Endoscopic transorbital surgery for Meckel's cave and middle cranial fossa tumors: surgical technique and early results Jeon1, C; Hong, CK; Woo, KI; Hong, SD; Nam, DH; Lee, JI; Choi, JW; Seol, HJ; Kong, DS
    View PubMed
  • J NEUROSURG 2019 10.3171/2018.3.JNS173233 Clinical and ophthalmological outcome of endoscopic transorbital surgery for cranioorbital tumors Kong1, DS; Young, SM; Hong, CK; Kim, YD; Hong, SD; Choi, JW; Seol, HJ; Lee, JI; Shin, HJ; Nam, DH; Woo, KI
    View PubMed
  • INT J CANCER 2019 10.1002/ijc.32054 Hypermutagenesis in untreated adult gliomas due to inherited mismatch mutations Sa1, JK; Choi, SW; Zhao, JF; Lee, Y; Zhang, J; Kong, DS; Choi, JW; Seol, HJ; Lee, JI; Iavarone, A; Rabadan, R; Nam, DH
    View PubMed
  • ACTA OTO-LARYNGOL 2019 10.1080/00016489.2019.1592223 Prognostic factors of facial nerve function after vestibular schwannoma removal via translabyrinthine approach Ahn1, J; Ryu, NG; Lim, J; Kang, M; Seol, HJ; Cho, YS
    View PubMed
  • J NEUROSURG 2019 10.3171/2017.12.JNS171943 Clinical and radiological outcomes of proactive Gamma Knife surgery for asymptomatic meningiomas compared with the natural course without intervention Kim1, KH; Kang, SJ; Choi, JW; Kong, DS; Seol, HJ; Nam, DH; Lee, JI
    View PubMed
  • WORLD NEUROSURG 2019 10.1016/j.wneu.2019.01.157 Prediction of IDH1 Mutation Status in Glioblastoma Using Machine Learning Technique Based on Quantitative Radiomic Data Lee1, MH; Kim, J; Kim, ST; Shin, HM; You, HJ; Choi, JW; Seol, HJ; Nam, DH; Lee, JI; Kong, DS
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0215280 Early prediction of neurological outcome after barbiturate coma therapy in patients undergoing brain tumor surgery Ryu1, JA; Jung, W; Jung, YJ; Kwon, DY; Kang, K; Choi, H; Kong, DS; Seol, HJ; Lee, JI
    View PubMed
  • J NEUROSURG 2019 10.3171/2017.11.JNS171337 Selection of endoscopic or transcranial surgery for tuberculum sellae meningiomas according to specific anatomical features: a retrospective multicenter analysis (KOSEN-002) Kong1, DS; Hong, CK; Hong, SD; Nam, DH; Lee, JI; Seol, HJ; Oh, J; Kim, DG; Kim, YH
    View PubMed
  • WORLD NEUROSURG 2019 10.1016/j.wneu.2018.11.090 Endoscopic Endonasal Versus Transorbital Surgery for Middle Cranial Fossa Tumors: Comparison of Clinical Outcomes Based on Surgical Corridors Lee1, MH; Hong, SD; Woo, KI; Kim, YD; Choi, JW; Seol, HJ; Lee, JI; Shin, HJ; Nam, DH; Kong, DS
    View PubMed
  • RADIOTHER ONCOL 2019 10.1016/j.radonc.2018.11.025 Cancer genetic markers according to radiotherapeutic response in patients with primary glioblastoma - Radiogenomic approach for precision medicine Yang1, K; Jung, SW; Shin, H; Lim, DH; Lee, JI; Kong, DS; Seol, HJ; Kim, ST; Nam, DH
    View PubMed
  • WORLD NEUROSURG 2019 10.1016/j.wneu.2018.10.151 Apparent Diffusion Coefficient as a Predictive Biomarker for Survival in Patients with Treatment-Naive Glioblastoma Using Quantitative Multiparametric Magnetic Resonance Profiling Kim1, BS; Kim, ST; Kim, JH; Seol, HJ; Nam, DH; Shin, HJ; Lee, JI; Kong, DS
    View PubMed
  • NEURO-ONCOLOGY 2019 10.1093/neuonc/noy123 Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma Cho1, HJ; Zhao, JF; Jung, SW; Ladewig, E; Kong, DS; Suh, YL; Lee, Y; Kim, D; Ahn, SH; Bordyuh, M; Kang, HJ; Sa, JK; Seo, YJ; Kim, ST; Lim, DH; Dho, YS; Lee, JI; Seol, HJ; Choi, JW; Park, WY; Park, CK; Rabadan, R; Nam, DH
    View PubMed
  • ACTA NEUROCHIR 2018 10.1007/s00701-018-3726-2 The influence of histology on the response of brain metastases to gamma knife radiosurgery: a propensity score-matched study Kim1, KH; Lee, MH; Cho, KR; Choi, JW; Kong, DS; Seol, HJ; Nam, DH; Lee, JI
    View PubMed
  • J NEUROSURG 2018 10.3171/2017.7.JNS171226 Clinical outcomes of intracranial solitary fibrous tumor and hemangiopericytoma: analysis according to the 2016 WHO classification of central nervous system tumors Kim1, BS; Kim, Y; Kong, DS; Nam, DH; Lee, JI; Suh, YL; Seol, HJ
    View PubMed
  • J NEURO-ONCOL 2018 10.1007/s11060-018-2972-8 Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study Koo1, T; Lim, DH; Seol, HJ; Dho, YS; Kim, IH; Chang, JH; Lee, J; Jung, TY; Gwak, HS; Cho, KH; Hong, CK; Lee, IJ; Kim, E; Kim, JH; Hong, YK; Jang, HS; Kim, CY; Kim, IA; Kim, SH; Kim, YI; Kim, EY; Kim, WC; Hong, S
    View PubMed
  • ASIA-PAC J CLIN ONCO 2018 10.1111/ajco.12861 Leptomeningeal enhancement on preoperative brain MRI in patients with glioblastoma and its clinical impact Kim1, H; Lim, DH; Kim, TG; Lee, JI; Nam, DH; Seol, HJ; Kong, DS; Choi, JW; Suh, YL; Kim, ST
    View PubMed
  • NAT GENET 2018 10.1038/s41588-018-0209-6 Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy Lee1, JK; Liu, ZQ; Sa, JK; Shin, S; Wang, JG; Bordyuh, M; Cho, H; Elliott, O; Chu, T; Choi, SW; Rosenbloom, DIS; Lee, IH; Shin, YJ; Kang, HJ; Kim, D; Kim, SY; Sim, MH; Kim, J; Lee, T; Seo, YJ; Shin, H; Lee, M; Kim, SH; Kwon, YJ; Oh, JW; Song, M; Kim, M; Kong, DS; Choi, JW; Seol, HJ; Lee, JI; Kim, ST; Park, JO; Kim, KM; Song, SY; Lee, JW; Kim, HC; Lee, JE; Choi, MG; Seo, SW; Shim, YM; Zo, JI; Jeong, BC; Yoon, Y; Ryu, GH; Kim, NKD; Bae, JS; Park, WY; Lee, J; Verhaak, RGW; Iavarone, A; Lee, J; Rabadan, R; Nam, DH
    View PubMed
  • J NEURO-ONCOL 2018 10.1007/s11060-018-2839-z Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study Koo1, T; Lim, DH; Seol, HJ; Park, CK; Kim, IH; Chang, JH; Lee, J; Jung, S; Gwak, HS; Cho, KH; Hong, CK; Lee, IJ; Kim, E; Kim, JH; Hong, YK; Jang, HS; Kim, CY; Kim, IA; Kim, SH; Kim, YI; Kim, EY; Kim, WC; Hong, S
    View PubMed
  • Cancer Med 2018 10.1002/cam4.1439 Identification of transcriptome signature for predicting clinical response to bevacizumab in recurrent glioblastoma Choi1, SW; Shin, H; Sa, JK; Cho, HJ; Koo, H; Kong, DS; Seol, HJ; Nam, DH
    View PubMed
  • J NEUROSURG 2018 10.3171/2016.12.JNS161920 Clinical outcomes of an endoscopic transclival and transpetrosal approach for primary skull base malignancies involving the clivus Kim1, YH; Jeon, C; Se, YB; Hong, SD; Seol, HJ; Lee, JI; Park, CK; Kim, DG; Jung, HW; Han, DH; Nam, DH; Kong, DS
    View PubMed
  • AM J CLIN ONCOL-CANC 2018 10.1097/COC.0000000000000224 Prognostic Value of Ki-67 Labeling Index and Postoperative Radiotherapy in WHO Grade II Meningioma Choi1, Y; Lim, DH; Yu, JI; Jo, K; Nam, DH; Seol, HJ; Lee, JI; Kong, DS; Suh, YL; Nam, H
    View PubMed
  • J CLIN NEUROSCI 2017 10.1016/j.jocn.2017.07.012 Reconstructive outcome of intraoperative cerebrospinal fluid leak after endoscopic endonasal surgery for tumors involving skull base Jeon1, CM; Hong, SD; Seol, HJ; Lee, JI; Nam, DH; Hwang, YJ; Kong, DS
    View PubMed
  • ACTA NEUROCHIR 2017 10.1007/s00701-017-3230-0 Optimal treatment of jugular foramen schwannomas: long-term outcome of a multidisciplinary approach for a series of 29 cases in a single institute Ryu1, SM; Lee, JI; Park, K; Choi, JW; Kong, DS; Nam, DH; Jeong, HS; Cho, YS; Seol, HJ
    View PubMed
  • J NEURO-ONCOL 2017 10.1007/s11060-017-2478-9 MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma Kim1, BS; Kong, DS; Seol, HJ; Nam, DH; Lee, JI
    View PubMed
  • Nat Genet. 2017 Apr;49(4):594-599. doi: 10.1038/ng.3806. Epub 2017 Mar 6. Spatiotemporal genomic architecture informs precision oncology in glioblastoma Lee JK11,2, Wang J3,4,5, Sa JK1,2,6, Ladewig E3,4, Lee HO7, Lee IH1,2, Kang HJ1,2, Rosenbloom DS3,4, Camara PG3,4, Liu Z3,4, van Nieuwenhuizen P3,4, Jung SW1,2,6, Choi SW1,2,6, Kim J1,2, Chen A3,4, Kim KT7, Shin S1,2,6, Seo YJ1,2, Oh JM1,2, Shin YJ1,2,7, Park CK8, Kong DS2, Seol HJ2, Blumberg A9, Lee JI2, Iavarone A10,11,12, Park WY6,7, Rabadan R3,4, Nam DH1,2,6.
    View PubMed
  • Cancer Res Treat. 2017 Jan;49(1):193-203. doi: 10.4143/crt.2015.473. Epub 2016 Jun 27. Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea Kim BS11, Seol HJ2, Nam DH2, Park CK3, Kim IH4, Kim TM5, Kim JH6, Cho YH6, Yoon SM7, Chang JH8, Kang SG8, Kim EH8, Suh CO9, Jung TY10, Lee KH11, Kim CY12, Kim IA13, Hong CK14, Yoo H15, Kim JH16, Kang SH17, Kang MK18, Kim EY19, Kim SH20, Chung DS21, Hwang SC22, Song JH23, Cho SJ24, Lee SI25, Lee YS26, Ahn KJ27, Kim SH28, Lim DH29, Gwak HS30, Lee SH31, Hong YK32.
    View PubMed
  • J Clin Neurosci. 2017 Jan;35:35-41. doi: 10.1016/j.jocn.2016.10.002. Epub 2016 Oct 18. Gamma knife radiosurgery for residual or recurrent intracranial hemangiopericytomas Kim BS11, Kong DS2, Seol HJ2, Nam DH2, Lee JI3.
    View PubMed
  • J Korean Neurosurg Soc. 2017 Jan 1;60(1):21-29. doi: 10.3340/jkns.2016.0404.005. Epub 2016 Dec 29. The Influence of Biomarker Mutations and Systemic Treatment on Cerebral Metastases from NSCLC Treated with Radiosurgery Lee MH11, Kong DS1, Seol HJ1, Nam DH1, Lee JI1.
    View PubMed
  • Cancer Med. 2016 Dec;5(12):3615-3621. doi: 10.1002/cam4.955. Epub 2016 Nov 23. Analysis of risk factors to predict communicating hydrocephalus following gamma knife radiosurgery for intracranial schwannoma Lee S11, Seo SW2, Hwang J1, Seol HJ1, Nam DH1, Lee JI1, Kong DS1.
    View PubMed
  • World Neurosurg. 2016 Nov;95:399-405. doi: 10.1016/j.wneu.2016.08.046. Epub 2016 Aug 24. Outcomes of Gamma Knife Radiosurgery in Combination with Crizotinib for Patients with Brain Metastasis from Non-Small Cell Lung Cancer Choi JW11, Kong DS1, Seol HJ1, Nam DH1, Yoo KH2, Sun JM2, Ahn JS2, Ahn MJ2, Park K2, Lee JI3.
    View PubMed
  • Neurosurg Rev. 2016 Oct;39(4):643-53. doi: 10.1007/s10143-016-0728-5. Epub 2016 May 4. Clinical outcome of neurofibromatosis type 2-related vestibular schwannoma: treatment strategies and challenges Kim BS11, Seol HJ2, Lee JI3, Shin HJ3, Park K3, Kong DS3, Nam DH3, Cho YS4.
    View PubMed
  • Medicine (Baltimore). 2016 Jul;95(27):e4109. doi: 10.1097/MD.0000000000004109. Integrative radiogenomic analysis for genomic signatures in glioblastomas presenting leptomeningeal dissemination You HJ11, Park HY, Kim J, Lee IH, Seol HJ, Lee JI, Kim ST, Kong DS, Nam DH.
    View PubMed
  • Clin Exp Metastasis. 2016 Jun;33(5):417-29. doi: 10.1007/s10585-016-9786-x. Epub 2016 Mar 8. Effect of bexarotene on differentiation of glioblastoma multiforme compared with ATRA Heo JC11, Jung TH1,2, Lee S1, Kim HY1, Choi G1, Jung M1, Jung D1, Lee HK1, Lee JO1, Park JH3, Hwang D4,3, Seol HJ5, Cho H6,7.
    View PubMed
  • World Neurosurg. 2016 Jun;90:496-503. doi: 10.1016/j.wneu.2016.03.050. Epub 2016 Mar 26. Serial Re-Expansion of Pituitary Gland Is Associated with Endocrinologic Recovery Cho KR11, Hong SD2, Hur KY3, Kim ST4, Seol HJ1, Lee JI1, Kong DS5, Nam DH6.
    View PubMed
  • Headache. 2016 Apr 4. doi: 10.1111/head.12801. Gamma Knife Radiosurgery for Trigeminal Neuralgia Secondary to Benign Lesions Cho KR11, Lee MH1, Im YS1, Kong DS1, Seol HJ1, Nam DH1, Lee JI1.
    View PubMed
  • World Neurosurg. 2016 May;89:215-22. doi: 10.1016/j.wneu.2016.01.038. Epub 2016 Jan 28. Functional Outcome of the Facial Nerve After Surgery for Vestibular Schwannoma: Prediction of Acceptable Long-Term Facial Nerve Function Based on Immediate Postoperative Facial Palsy Lee S11, Seol HJ2, Park K1, Lee JI1, Nam DH1, Kong DS1, Cho YS3.
    View PubMed
  • Cancer Res. 2016 Mar 1;76(5):1044-54. doi: 10.1158/0008-5472.CAN-14-2611. Epub 2015 Dec 16. Novel Morphologic and Genetic Analysis of Cancer Cells in a 3D Microenvironment Identifies STAT3 as a Regulator of Tumor Permeability Barrier Function Park MC11, Jeong H2, Son SH3, Kim Y4, Han D4, Goughnour PC4, Kang T3, Kwon NH3, Moon HE5, Paek SH5, Hwang D6, Seol HJ7, Nam DH7, Kim S8.
    View PubMed
  • Oncotarget. 2016 Mar 8;7(10):11526-38. doi: 10.18632/oncotarget.7115. Integrative radiogenomic analysis for multicentric radiophenotype in glioblastoma Kong DS11,2,3,4, Kim J2,3,4, Lee IH2,3,4, Kim ST5, Seol HJ1, Lee JI1, Park WY6, Ryu G7, Wang Z7, Ma'ayan A7, Nam DH1,2,3,4.
    View PubMed
  • J Korean Neurosurg Soc. 2016 Jan;59(1):44-51. doi: 10.3340/jkns.2016.59.1.44. Epub 2016 Jan 20. Malignant Glioma with Neuronal Marker Expression : A Clinicopathological Study of 18 Cases Kim HR11, Lee JJ2, Lee JI3, Nam DH3, Suh YL2, Seol HJ3.
    View PubMed
  • World Neurosurg. 2015 Dec;84(6):1752-7. doi: 10.1016/j.wneu.2015.07.045. Epub 2015 Jul 26. Effectiveness of Postoperative Gamma Knife Radiosurgery to the Tumor Bed After Resection of Brain Metastases Choi JW11, Im YS1, Kong DS1, Seol HJ1, Nam DH1, Lee JI2.
    View PubMed
  • J Neurooncol. 2015 Nov;125(2):331-8. doi: 10.1007/s11060-015-1915-x. Epub 2015 Sep 15. Outcome of gamma knife radiosurgery for metastatic brain tumors derived from non-small cell lung cancer Cho KR11, Lee MH1, Kong DS1, Seol HJ1, Nam DH1, Sun JM2, Ahn JS2, Ahn MJ2, Park K2, Kim ST3, Lim do H4, Lee JI5.
    View PubMed
  • Eur J Med Chem. 2015 Oct 20;103:210-22. doi: 10.1016/j.ejmech.2015.08.001. Epub 2015 Aug 4. Discovery of potent and selective cytotoxic activity of new quinazoline-ureas against TMZ-resistant glioblastoma multiforme (GBM) Elkamhawy A11, Viswanath AN2, Pae AN2, Kim HY3, Heo JC3, Park WK3, Lee CO3, Yang H4, Kim KH4, Nam DH5, Seol HJ5, Cho H6, Roh EJ7.
    View PubMed
  • Cancer Cell. 2015 Sep 14;28(3):318-28. doi: 10.1016/j.ccell.2015.07.013. Spatiotemporal Evolution of the Primary Glioblastoma Genome Kim J11, Lee IH2, Cho HJ3, Park CK4, Jung YS5, Kim Y6, Nam SH6, Kim BS5, Johnson MD7, Kong DS5, Seol HJ5, Lee JI5, Joo KM8, Yoon Y3, Park WY9, Lee J10, Park PJ11, Nam DH12.
    View PubMed
  • J Clin Neurosci. 2015 Sep;22(9):1425-9. doi: 10.1016/j.jocn.2015.02.036. Epub 2015 Jun 29. Prognostic impact of molecular phenotype in patients with recurrent anaplastic glioma treated with prolonged administration of temozolomide Kong DS11, Kim HR2, Choi YR3, Seol HJ1, Lee JI1, Nam DH4.
    View PubMed
  • J Neurooncol. 2015 Aug;124(1):101-10. doi: 10.1007/s11060-015-1808-z. Epub 2015 May 31. Prognostic implication of progression pattern after anti-VEGF bevacizumab treatment for recurrent malignant gliomas Kim BS11, Kim SK, Choi SH, Lee SH, Seol HJ, Nam DH, Lee JI, Park CK, Kong DS.
    View PubMed
  • Int J Cancer. 2015 May 1;136(9):2065-77. doi: 10.1002/ijc.29248. Epub 2014 Oct 10. Tpl2 induces castration resistant prostate cancer progression and metastasis Lee HW11, Cho HJ, Lee SJ, Song HJ, Cho HJ, Park MC, Seol HJ, Lee JI, Kim S, Lee HM, Choi HY, Nam DH, Joo KM.
    View PubMed
  • Am J Rhinol Allergy. 2015 May-Jun;29(3):221-5. doi: 10.2500/ajra.2015.29.4165. Endoscopic binostril versus transnasal transseptal microscopic pituitary surgery: Sinonasal quality of life and olfactory function Hong SD11, Nam do H, Seol HJ, Choi NY, Kim HY, Chung SK, Dhong HJ.
    View PubMed
  • Acta Neurochir (Wien). 2015 Apr;157(4):569-76. doi: 10.1007/s00701-015-2344-5. Epub 2015 Feb 8. Optimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcome Noh JH11, Lee MH, Kim WS, Lim do H, Kim ST, Kong DS, Nam DH, Lee JI, Seol HJ.
    View PubMed
  • Clin Cancer Res. 2015 Mar 1;21(5):1172-82. doi: 10.1158/1078-0432.CCR-14-1589. Epub 2014 Dec 30. Patient-Derived Xenografts from Non-Small Cell Lung Cancer Brain Metastases Are Valuable Translational Platforms for the Development of Personalized Targeted Therapy Lee HW11, Lee JI2, Lee SJ3, Cho HJ2, Song HJ4, Jeong da E5, Seo YJ2, Shin S5, Joung JG6, Kwon YJ7, Choi YL8, Park WY9, Lee HM10, Seol HJ2, Shim YM11, Joo KM12, Nam DH13.
    View PubMed
  • J Clin Neurosci. 2015 Mar;22(3):468-73. doi: 10.1016/j.jocn.2014.09.018. Epub 2015 Jan 13. Outcome of salvage treatment for recurrent glioblastoma Kim HR11, Kim KH2, Kong DS2, Seol HJ2, Nam DH2, Lim do H3, Lee JI4.
    View PubMed
  • J Neurooncol. 2015 Jan;121(2):311-8. doi: 10.1007/s11060-014-1634-8. Epub 2014 Dec 9. Outcome of radiosurgery for recurrent malignant gliomas: assessment of treatment response using relative cerebral blood volume Kim HR11, Kim SH, Lee JI, Seol HJ, Nam DH, Kim ST, Park K, Kim JH, Kong DS.
    View PubMed
  • J Korean Neurosurg Soc. 2014 Sep;56(3):194-9. doi: 10.3340/jkns.2014.56.3.194. Epub 2014 Sep 30. Clinical Features and Treatment Outcome of Chordoid Meningiomas in a Single Institute Jee TK11, Jo KI1, Seol HJ1, Kong DS1, Lee JI1, Shin HJ1.
    View PubMed
  • J Korean Neurosurg Soc. 2014 Sep;56(3):237-42. doi: 10.3340/jkns.2014.56.3.237. Epub 2014 Sep 30. Microsurgical Treatment and Outcome of Pediatric Supratentorial Cerebral Cavernous Malformation Noh JH11, Cho KR1, Yeon JY1, Seol HJ1, Shin HJ1.
    View PubMed
  • J Korean Neurosurg Soc. 2014 Sep;56(3):281-3. doi: 10.3340/jkns.2014.56.3.281. Epub 2014 Sep 30. Endoscopic Decompression for Optic Neuropathy in McCune-Albright Syndrome Noh JH11, Kong DS1, Seol HJ1, Shin HJ1.
    View PubMed
  • J Neurooncol. 2014 Sep;119(2):405-12. doi: 10.1007/s11060-014-1507-1. Epub 2014 Jun 26. Efficacy of postoperative radiotherapy for high grade meningiomas Choi Y11, Lim DH, Jo K, Nam DH, Seol HJ, Lee JI.
    View PubMed
  • PLoS One. 2014 Aug 1;9(8):e103327. doi: 10.1371/journal.pone.0103327. eCollection 2014. Translational Validation of Personalized Treatment Strategy Based on Genetic Characteristics of Glioblastoma Oh YT11, Cho HJ1, Kim J2, Lee JH3, Rho K3, Seo YJ4, Choi YS4, Jung HJ4, Song HS4, Kong DS5, Seol HJ5, Lee JI5, Yoon Y1, Kim S3, Nam DH6, Joo KM7.
    View PubMed
  • Childs Nerv Syst. 2014 Jun;30(6):1055-60. doi: 10.1007/s00381-014-2367-x. Epub 2014 Jan 31. Neuroendoscopic biopsy of pediatric brain tumors with small ventricle Lee MH11, Kim HR, Seol HJ, Shin HJ.
    View PubMed
  • Stroke. 2014 Apr;45(4):1173-6. doi: 10.1161/STROKEAHA.113.004125. Epub 2014 Feb 18. Unilateral Intracranial Arteriopathy in Pediatric Stroke Course, Outcome, and Prediction of Reversible Arteriopathy Yeon JY11, Shin HJ, Seol HJ, Kim JS, Hong SC.
    View PubMed
  • Acta Neurochir (Wien). 2014 Apr;156(4):641-51. doi: 10.1007/s00701-014-2020-1. Epub 2014 Feb 20. Outcome of conventional treatment and prognostic factor in elderly glioblastoma patients Oh SW11, Jee TK, Kong DS, Nam DH, Lee JI, Seol HJ.
    View PubMed
  • Anticancer Res. 2013 Dec;33(12):5335-42. Genetically-engineered Human Neural Stem Cells with Rabbit Carboxyl Esterase Can Target CNS Lymphoma Kang W11, Jin J, Yang H, Seol HJ, Kim KH, Lee JI, Kim SU, Joo KM, Nam DH.
    View PubMed
  • Clin Cancer Res. 2013 Nov 1;19(21):5879-89. doi: 10.1158/1078-0432.CCR-13-1181. Epub 2013 Aug 30. Alpha-Smooth Muscle Actin (ACTA2) Is Required for Metastatic Potential of Human Lung Adenocarcinoma Lee HW11, Park YM, Lee SJ, Cho HJ, Kim DH, Lee JI, Kang MS, Seol HJ, Shim YM, Nam DH, Kim HH, Joo KM.
    View PubMed
  • Clin Exp Metastasis. 2013 Oct;30(7):845-54. doi: 10.1007/s10585-013-9584-7. Epub 2013 Apr 27. Gene silencing of c-Met leads to brain metastasis inhibitory effects Lee SJ11, Seol HJ, Lee HW, Kang WY, Kang BG, Jin J, Jo MY, Jin Y, Lee JI, Joo KM, Nam DH.
    View PubMed
  • Oncol Rep. 2013 Sep;30(3):1101-6. doi: 10.3892/or.2013.2584. Epub 2013 Jul 3. Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors Kang W11, Seol HJ, Seong DH, Kim J, Kim Y, Kim SU, Nam DH, Joo KM.
    View PubMed
  • Neuro Oncol. 2013 Aug;15(8):1096-101. doi: 10.1093/neuonc/not069. Epub 2013 Jun 25. A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma Park CK11, Kim JH, Nam DH, Kim CY, Chung SB, Kim YH, Seol HJ, Kim TM, Choi SH, Lee SH, Heo DS, Kim IH, Kim DG, Jung HW.
    View PubMed
  • Acta Neurochir (Wien). 2013 Mar;155(3):399-405. doi: 10.1007/s00701-012-1576-x. Epub 2012 Dec 14. Radiosurgery to palliate symptoms in brain metastases from uterine cervix cancer Chung SB11, Jo KI, Seol HJ, Nam DH, Lee JI.
    View PubMed
  • Neuro Oncol. 2013 Feb;15(2):161-71. doi: 10.1093/neuonc/nos299. Epub 2012 Dec 20. Wnt/beta-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells Kim KH11, Seol HJ, Kim EH, Rheey J, Jin HJ, Lee Y, Joo KM, Lee J, Nam DH.
    View PubMed
  • Cell Rep. 2013 Jan 31;3(1):260-73. doi: 10.1016/j.celrep.2012.12.013. Epub 2013 Jan 17. Patient-Specific Orthotopic Glioblastoma Xenograft Models Recapitulate the Histopathology and Biology of Human Glioblastomas In Situ Joo KM11, Kim J, Jin J, Kim M, Seol HJ, Muradov J, Yang H, Choi YL, Park WY, Kong DS, Lee JI, Ko YH, Woo HG, Lee J, Kim S, Nam DH.
    View PubMed
  • Acta Neurochir (Wien). 2013 Jan;155(1):25-31. doi: 10.1007/s00701-012-1551-6. Epub 2012 Nov 15. Clinical outcomes of tuberculum sellae meningiomas focusing on reversibility of postoperative visual function Seol HJ11, Park HY, Nam DH, Kong DS, Lee JI, Kim JH, Park K.
    View PubMed
  • Int J Oncol. 2012 Dec;41(6):2013-20. doi: 10.3892/ijo.2012.1663. Epub 2012 Oct 15. Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer Lee HW11, Seol HJ, Choi YL, Ju HJ, Joo KM, Ko YH, Lee JI, Nam DH.
    View PubMed
  • J Clin Neurosci. 2012 Dec;19(12):1654-8. doi: 10.1016/j.jocn.2011.11.044. Epub 2012 Oct 11. Treatment outcomes after surgical resection of midline anterior skull base meningiomas at a single center Park HY11, Seol HJ, Nam DH, Lee JI, Kong DS, Kim JH, Park K.
    View PubMed
  • Mol Cells. 2012 Sep;34(3):329-34. Epub 2012 Sep 3. MicroRNA-146a suppresses metastatic activity in brain metastasis Hwang SJ11, Seol HJ, Park YM, Kim KH, Gorospe M, Nam DH, Kim HH.
    View PubMed
  • Acta Neurochir (Wien). 2012 Sep;154(9):1679-84. doi: 10.1007/s00701-012-1350-0. Epub 2012 Apr 26. Risk factors and tumor response associated with hydrocephalus after gamma knife radiosurgery for vestibular schwannoma Lee SH11, Seol HJ, Kong DS, Nam DH, Park K, Kim JH, Lee JI.
    View PubMed
  • Cancer Lett. 2011 Dec 8;311(2):152-9. doi: 10.1016/j.canlet.2011.07.001. Epub 2011 Jul 14. Genetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancer Seol HJ11, Jin J, Seong DH, Joo KM, Kang W, Yang H, Kim J, Shin CS, Kim Y, Kim KH, Kong DS, Lee JI, Aboody KS, Lee HJ, Kim SU, Nam DH.
    View PubMed
  • Oncol Res. 2011;19(8-9):381-90. The Expression of DNA Damage Checkpoint Proteins and Prognostic Implication in Metastatic Brain Tumors Seol HJ11, Yoo HY, Jin J, Joo KM, Kim HS, Yoon SJ, Choi SH, Kim Y, Pyo HR, Lim DH, Kim W, Um HD, Kim JH, Lee JI, Nam DH.
    View PubMed
  • Oncol Rep. 2011 Aug;26(2):423-30. doi: 10.3892/or.2011.1325. Epub 2011 May 26. Prognostic implications of the DNA damage response pathway in glioblastoma Seol HJ11, Yoo HY, Jin J, Joo KM, Kong DS, Yoon SJ, Yang H, Kang W, Lim DH, Park K, Kim JH, Lee JI, Nam DH.
    View PubMed